PerkinElmer to Acquire Oxford Immunotec Global PLC
|
By LabMedica International staff writers Posted on 08 Jan 2021 |
|
Illustration
PerkinElmer, Inc. (Waltham, MA; USA) has reached an agreement to acquire Oxford Immunotec Ltd. (Abingdon, UK) that will allow the company to grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection.
The deal will enable PerkinElmer to combine its channel expertise and leading workflow and testing capabilities with Oxford Immunotec’s leading proficiencies in T cell immunology with its proprietary test kits for latent tuberculosis. Oxford Immunotec is the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. The company’s T-SPOT.TB test is used for diagnosing infection with tuberculosis and it has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the US, where it has received pre-market approval from the FDA, Europe, where it has obtained a CE mark, as well as Japan and China.
“Tuberculosis remains one of the leading infectious causes of death, with close to one quarter of the world’s population infected,” said Prahlad Singh, PhD, President and Chief Executive Officer of PerkinElmer. “We believe Oxford Immunotec’s diagnostic testing solution plays an important role in slowing the spread and saving lives. Oxford Immunotec’s highly sensitive test and their team’s passion for solving complex health issues make it a natural fit with PerkinElmer’s mission and together, we believe will accelerate development of robust solutions to help detect infectious disease.”
“We are delighted to be joining the PerkinElmer family. We believe this transaction is great for our shareholders, our employees and our customers,” said Peter Wrighton-Smith, PhD, Chief Executive Officer of Oxford Immunotec. “Access to PerkinElmer’s global reach and automation experience will enable us to accelerate our growth journey and make a growing impact in the field of infectious disease.”
The deal will enable PerkinElmer to combine its channel expertise and leading workflow and testing capabilities with Oxford Immunotec’s leading proficiencies in T cell immunology with its proprietary test kits for latent tuberculosis. Oxford Immunotec is the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. The company’s T-SPOT.TB test is used for diagnosing infection with tuberculosis and it has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the US, where it has received pre-market approval from the FDA, Europe, where it has obtained a CE mark, as well as Japan and China.
“Tuberculosis remains one of the leading infectious causes of death, with close to one quarter of the world’s population infected,” said Prahlad Singh, PhD, President and Chief Executive Officer of PerkinElmer. “We believe Oxford Immunotec’s diagnostic testing solution plays an important role in slowing the spread and saving lives. Oxford Immunotec’s highly sensitive test and their team’s passion for solving complex health issues make it a natural fit with PerkinElmer’s mission and together, we believe will accelerate development of robust solutions to help detect infectious disease.”
“We are delighted to be joining the PerkinElmer family. We believe this transaction is great for our shareholders, our employees and our customers,” said Peter Wrighton-Smith, PhD, Chief Executive Officer of Oxford Immunotec. “Access to PerkinElmer’s global reach and automation experience will enable us to accelerate our growth journey and make a growing impact in the field of infectious disease.”
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Specimen Radiography System
TrueView 200 Pro
Latest Industry News
- Werfen and VolitionRx Partner to Advance Diagnostic Testing for Antiphospholipid Syndrome
- Siemens Healthineers and Carna Health Partner to Advance Kidney Care Innovation
- Vircell Launches New Website for Molecular Control Products
- Tempus AI Acquires Digital Pathology Company Paige
- New Manual to Help Clinicians Better Diagnose and Treat Infection-Associated Chronic Illness
- WHO Releases Updated Guidance on Tuberculosis Diagnosis
- Pioneering Collaboration to Transform Pediatric Cancer Diagnostics and Research
- Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio
- New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis
- IFCC WorldLab 2026 To Be Held in India on October 25-29
- PHASE Scientific and Lumos Diagnostics Partner on Rapid POC Test for Bacterial Respiratory Infection
- QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests
- BD Biosciences & Diagnostic Solutions to Merge with Waters
- 2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics
- Quanterix Completes Acquisition of Akoya Biosciences
- Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more
Molecular Diagnostics
view channel
Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more
Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
Hematologic disorders are often diagnosed using painful, invasive, and expensive bone marrow aspiration or biopsy procedures. These approaches limit patient compliance and broader utility, leaving a need... Read more
Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, and cases are rising each year. Unlike cervical cancers linked to HPV, there is currently no screening test for... Read more
Hematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more
Immunology
view channel
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis
Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read more
Technology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
